Is Your Pharmacy Ready for the Shift from AbbVie’s Humira to New Biosimilars?
AbbVie’s Humira monopoly is nearing its end. No monopoly in the history of the pharmaceutical industry has been as successful as AbbVie’s Humira. The injectable drug, manufactured by the spin-off of Abbott Laboratories, is used to treat a wide variety of inflammatory diseases including rheumatoid arthritis, ulcerative colitis, and Crohn’s disease, and is the most […]
